Gyre Therapeutics
GYRE
GYRE
63 hedge funds and large institutions have $107M invested in Gyre Therapeutics in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $117M → $107M (-$10.3M)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Holders
63
Holding in Top 10
1
Calls
$3.41M
Puts
$1.12M
Top Buyers
| 1 | +$2.18M | |
| 2 | +$2M | |
| 3 | +$1.58M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$1.36M |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$541K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$2.93M | |
| 3 | -$1.97M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.4M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$621K |